Tag: brain imaging
Hyperfine announces European launch with recent CE-mark approval
Hyperfine has announced the CE-mark approval of its latest generation of artificial intelligence (AI)-powered Swoop system software under the European Medical Device Regulation (MDR).
This...
Spryte Medical receives Breakthrough Device designation from US FDA for neuro...
Spryte Medical has announced that its neuro optical coherence tomography (nOCT) technology has been granted Breakthrough Device designation by the US Food and Drug Administration (FDA)....
US researchers pioneer new brain imaging technique through ‘clear window’ in...
In what has been described as the first study of its kind, researchers from the Keck School of Medicine at the University of Southern...
‘TACTICS’ intervention shows promise for improving EVT access in Australia
TACTICS, a non-randomised intervention trial that aimed to optimise workflow and implement specialised imaging, has shown promise in improving access to endovascular therapy (EVT)...
Hyperfine to expand into European markets with initial focus on France,...
Hyperfine has announced that it has entered into agreements with three experienced and accomplished distributors to support commercial expansion plans of the Swoop system—the...
New UK NICE guidance endorses AI-derived software in stroke assessments
A new guidance document from the UK National Institute of Health and Care Excellence (NICE) has endorsed National Health Service (NHS) deployment of two...
TENSION results show improved functional outcomes and reduced mortality with stroke...
New results from the TENSION study—presented recently at the 15th World Stroke Congress (WSC; 10–12 October, Toronto, Canada) by Götz Thomalla (University Medical Center...
Hyperfine gains US FDA clearance for AI-powered software update of Swoop...
Hyperfine has announced US Food and Drug Administration (FDA) clearance of updated software for its portable magnetic resonance brain imaging technology, the Swoop system....
Hyperfine launches international study to assess Swoop system in stroke diagnosis...
Hyperfine, the company that created the Swoop system—which it claims is the world’s first US Food and Drug Administration (FDA)-cleared portable magnetic resonance (MR) brain imaging...
Incomplete imaging of transient ischaemic attack increases subsequent stroke risk
Transient ischaemic attacks (TIAs) encountered with incomplete neurovascular imaging in emergency departments (EDs) have been associated with higher odds of subsequent stroke within 90...
Cercare and ConcertAI partner to improve neurovascular clinical workflows
Cercare Medical has announced it will be bringing its neurovascular clinical workflows into ConcertAI's TeraRecon Eureka clinical artificial intelligence (AI) platform as part of...
Incepto partners with Avicenna.AI to improve stroke management in Europe
Incepto, a distributor and co-creator of artificial intelligence (AI) solutions applied to medical imaging, has signed a partnership with Avicenna.AI to enrich its platform...
RSNA 2022: New research improves understanding of ADHD, migraine and post-COVID...
The ongoing annual meeting of the Radiological Society of North America (RSNA; 27 November–1 December 2022, Chicago, USA) has seen a plethora of new...
Avicenna.AI partners with CARPL.ai to provide AI-powered radiology solutions
Avicenna.AI has today announced a distribution agreement with CARPL.ai—a company providing a technology platform that enables service-provider-oriented testing, validation and deployment of artificial intelligence...
SyntheticMR and Siemens Healthineers extend collaboration with new license agreement
SyntheticMR has entered a general software license agreement for distribution with Siemens Healthineers. The agreement enables Siemens Healthineers to market, sell and distribute SyntheticMR's...
Neurosurgery with Surgical Theater’s VR and AR technologies set for first...
Rambam Healthcare Medical Center in Haifa, Israel is set to become the first medical centre in Israel to use virtual reality (VR) and augmented...
SpinTech earns FDA clearance for rapid, quantitative brain-imaging technology
The US Food and Drug Administration (FDA) has granted 510(k) approval for STAGE (Strategically acquired gradient echo), the latest magnetic resonance imaging (MRI) technology...
